Evidence map›Paper›PMID 32008573›Full record

ArticleFluids and barriers of the CNS2020

Human CD4

Hideaki Nishihara, Sasha Soldati, Adrien Mossu, Maria Rosito, Henriette Rudolph, William A Muller, Daniela Latorre, Federica Sallusto, Mireia Sospedra, Roland Martin and 5 more

Open access · goldAbstract read
In one paragraph

Article in Fluids and barriers of the CNS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. The spleen-brain axis in Alzheimer's disease and related dementias: Integrating immune and metabolic regulation.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Engineering memory T cells as a platform for long-term enzyme replacement therapy in lysosomal storage disorders.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  16. Review
  17. T Cells Trafficking into the Brain in Aging and Alzheimer's Disease.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Review
  18. CD4Neurobiology of stress · 2024
    Article
  19. Article
  20. Brain regulatory T cells.Nature reviews. Immunology · 2024
    Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 7 countries.

Hideaki NishiharaTheodor Kocher Institute, University of Bern, Bern, Switzerland.
Sasha SoldatiTheodor Kocher Institute, University of Bern, Bern, Switzerland.
Adrien MossuTheodor Kocher Institute, University of Bern, Bern, Switzerland.
Maria RositoTheodor Kocher Institute, University of Bern, Bern, Switzerland.
Henriette RudolphDepartment of Pediatrics, Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
William A MullerFeinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Daniela LatorreInstitute for Research in Biomedicine, Università Della Svizzera Italiana, Bellinzona, Switzerland.
Federica SallustoInstitute for Research in Biomedicine, Università Della Svizzera Italiana, Bellinzona, Switzerland.
Mireia SospedraNeuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
Roland MartinNeuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
Hiroshi IshikawaLaboratory of Clinical Regenerative Medicine, Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Tobias TenenbaumDepartment of Pediatrics, Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Horst SchrotenDepartment of Pediatrics, Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Fabien GosseletBlood Brain Barrier Laboratory, University of Artois, Lens, France.
Britta EngelhardtTheodor Kocher Institute, University of Bern, Bern, Switzerland. bengel@tki.unibe.ch.ORCID http://orcid.org/0000-0003-3059-9846
University of Bern · CHHeidelberg University · DEUniversity of Zurich · CHBoard of the Swiss Federal Institutes of Technology · CHETH Zurich · CHLaboratoire Jean Perrin · FRNorthwestern University · USUniversity of Tsukuba · JP

Funding

TWO NOVEL VASCULAR ADHESION MOLECULES: PECAM AND HEC-1R01HL046849 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MULLER, WILLIAM A · 1991 to 2019
$6.7M
PECAM-INDEPENDENT TRANSENDOTHELIAL MIGRATIONR01HL064774 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI MULLER, WILLIAM A · 2000 to 2020
$3.3M
NHLBI NIH HHS R01 HL046849NHLBI NIH HHS R01 HL064774Swiss National Science Foundation CRSII3_154483
6 · The paper itself

Abstract

backgroundThe brain barriers establish compartments in the central nervous system (CNS) that significantly differ in their communication with the peripheral immune system. In this function they strictly control T-cell entry into the CNS. T cells can reach the CNS by either crossing the endothelial blood-brain barrier (BBB) or the epithelial blood-cerebrospinal fluid barrier (BCSFB) of the choroid plexus (ChP).

objectiveAnalysis of the cellular and molecular mechanisms involved in the migration of different human CD4

methodsHuman in vitro models of the BBB and BCSFB were employed to study the migration of circulating and CNS-entry experienced CD4

resultsWhile under non-inflammatory conditions Th1* and Th1 cells preferentially crossed the BBB, under inflammatory conditions the migration rate of all Th subsets across the BBB was comparable. The migration of all Th subsets across the BCSFB from the same donor was 10- to 20-fold lower when compared to their migration across the BBB. Interestingly, Th17 cells preferentially crossed the BCSFB under both, non-inflamed and inflamed conditions. Barrier-crossing experienced Th cells sorted from CSF of MS patients showed migratory characteristics indistinguishable from those of circulating Th cells of healthy donors. All Th cell subsets could additionally cross the BCSFB from the CSF to ChP stroma side. T-cell migration across the BCSFB involved epithelial ICAM-1 irrespective of the direction of migration.

conclusionsOur observations underscore that different Th subsets may use different anatomical routes to enter the CNS during immune surveillance versus neuroinflammation with the BCSFB establishing a tighter barrier for T-cell entry into the CNS compared to the BBB. In addition, CNS-entry experienced Th cell subsets isolated from the CSF of MS patients do not show an increased ability to cross the brain barriers when compared to circulating Th cell subsets from healthy donors underscoring the active role of the brain barriers in controlling T-cell entry into the CNS. Also we identify ICAM-1 to mediate T cell migration across the BCSFB.

Indexed as

Biological TransportBlood-Brain BarrierCD4-Positive T-LymphocytesCell MovementCentral Nervous SystemChoroid PlexusEndothelial CellsEpithelial CellsHumansT-Lymphocyte SubsetsAdhesion moleculeBlood–brain barrierBlood-cerebrospinal fluid barrierMultiple sclerosisT-cell migration

Identifiers

PMID32008573
PMCPMC6996191
OpenAlexW3004513021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.